We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$2.68B
AUM Growth
+$190M
Cap. Flow
+$224M
Cap. Flow %
8.36%
Top 10 Hldgs %
33.25%
Holding
1,438
New
142
Increased
550
Reduced
287
Closed
78
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYD icon
701
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.67B
$77K ﹤0.01%
1,739
+350
+25% +$15.4K
XT icon
702
iShares Future Exponential Technologies ETF
XT
$3.98B
$77K ﹤0.01%
1,342
JULM
703
FT Vest U.S. Equity Max Buffer ETF - July
JULM
$29.7M
$77K ﹤0.01%
2,471
EOCT icon
704
Innovator Emerging Markets Power Buffer ETF October
EOCT
$106M
$76K ﹤0.01%
2,861
+443
+18% +$11.7K
QTEC icon
705
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.77B
$76K ﹤0.01%
439
-1
-0.2% -$192
SPBO icon
706
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
$76K ﹤0.01%
2,630
SPHD icon
707
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
$75K ﹤0.01%
1,485
-47
-3% -$2.31K
ZNOV
708
Innovator Equity Defined Protection ETF - 1 Yr November
ZNOV
$105M
$75K ﹤0.01%
3,006
DOCT
709
FT Vest US Equity Deep Buffer ETF October
DOCT
$388M
$74K ﹤0.01%
1,939
SRE icon
710
Sempra
SRE
$55.3B
$74K ﹤0.01%
1,033
+176
+21% +$13.7K
YMAR icon
711
FT Vest International Equity Moderate Buffer ETF March
YMAR
$164M
$74K ﹤0.01%
3,096
FRME icon
712
First Merchants
FRME
$2.65B
$73K ﹤0.01%
1,800
AKAM icon
713
Akamai
AKAM
$16.9B
$72K ﹤0.01%
892
CVS icon
714
CVS Health
CVS
$122B
$72K ﹤0.01%
1,060
-2,802
-73% -$168K
FUMB icon
715
First Trust Ultra Short Duration Municipal ETF
FUMB
$248M
$72K ﹤0.01%
+3,575
New +$71.9K
GJUL icon
716
FT Vest US Equity Moderate Buffer ETF July
GJUL
$406M
$72K ﹤0.01%
2,016
TRNO icon
717
Terreno Realty
TRNO
$7.44B
$72K ﹤0.01%
1,136
+5
+0.4% +$324
CCI icon
718
Crown Castle
CCI
$31.3B
$71K ﹤0.01%
680
-16
-2% -$1.49K
FBT icon
719
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$71K ﹤0.01%
+418
New +$72.6K
SCMB icon
720
Schwab Municipal Bond ETF
SCMB
$3.98B
$71K ﹤0.01%
2,791
FMHI icon
721
First Trust Municipal High Income ETF
FMHI
$1.01B
$70K ﹤0.01%
1,455
+1,443
+12,025% +$69.8K
SOXX icon
722
iShares Semiconductor ETF
SOXX
$45.3B
$70K ﹤0.01%
376
-151
-29% -$32.2K
TLT icon
723
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$70K ﹤0.01%
766
-27,053
-97% -$2.41M
BIIB icon
724
Biogen
BIIB
$30.5B
$69K ﹤0.01%
501
ITW icon
725
Illinois Tool Works
ITW
$84B
$69K ﹤0.01%
280
+25
+10% +$6.42K

Similar funds

Capital Analysts LLC's Q1 2025 Portfolio in Review

As of Q1 2025, Capital Analysts LLC held 1,438 positions worth $2.68B, up 7.6% from $2.49B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Capital Analysts LLC deployed $224M of net new capital in Q1 2025, opening 142 new positions and adding to 550 existing holdings. Its largest new stake was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $56.5M trimmed.

  • Capital Analysts LLC's largest Q1 2025 buy was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.
  • Capital Analysts LLC added most to Fidelity Enhanced Mid Cap Core ETF in Q1 2025, an estimated $62.4M increase.
  • Capital Analysts LLC's biggest Q1 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $56.5M.
  • Capital Analysts LLC fully exited West Pharmaceutical in Q1 2025, selling an estimated $642K.
  • Capital Analysts LLC's ten largest holdings make up 33% of its $2.68B portfolio in Q1 2025.
  • Capital Analysts LLC opened 142 new positions and closed 78 in Q1 2025.
  • Capital Analysts LLC's portfolio value rose 7.6% quarter-over-quarter to $2.68B.

Based on Capital Analysts LLC's 13F filing for Q1 2025, filed 14 May 2025.